Differential expression of α-2,3-sialyltransferases and α-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 1, 2010, Pages 80-89

  Carvalho, A S ^a   Harduin Lepers, A ^b   Magalhaes A ^a   Machado, E ^c   Mendes, N ^a   Costa, L T ^a   Matthiesen, R ^a   Almeida, R ^a,d   Costa, J ^c   Reis, C A ^a,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^c INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^d Faculty of Engineering of Porto   (Portugal)

Author keywords

Cell confluence; Gastric cancer; mRNA expression; Sialyl Lewis a and sialyl Lewis x; Sialyltransferase

Indexed keywords

ALPHA 1,3 FUCOSYLTRANSFERASE; ALPHA 2,3 SIALYLTRANSFERASE; BLOOD GROUP ANTIGEN; GLYCOPROTEIN; SIALYL LEWIS A ANTIGEN; SIALYL LEWIS X ANTIGEN; SIALYLTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GASTROINTESTINAL CARCINOMA; GENE OVEREXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL COUNT; CELL EXTRACTS; CELL LINE, TUMOR; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGOSACCHARIDES; SIALYLTRANSFERASES; STOMACH NEOPLASMS; TRANSFECTION;

EID: 70649087034     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.09.010     Document Type: Article

References (61)

1. Amado M., Carneiro F., Seixas M., Clausen H., and Sobrinho-Simoes M. Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology 114 (1998) 462-470
2. Baeckstrom D., Hansson G.C., Nilsson O., Johansson C., Gendler S.J., and Lindholm L. Purification and characterization of a membrane-bound and a secreted mucin-type glycoprotein carrying the carcinoma-associated sialyl-Lea epitope on distinct core proteins. J Biol Chem 266 (1991) 21537-21547
3. Baeckstrom D., Nilsson O., Price M.R., Lindholm L., and Hansson G.C. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody. Cancer Res 53 (1993) 755-761
4. Baeckstrom D., Zhang K., Asker N., Ruetschi U., Ek M., and Hansson G.C. Expression of the leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line. J Biol Chem 270 (1995) 13688-13692
5. Becker D.J., and Lowe J.B. Fucose: biosynthesis and biological function in mammals. Glycobiology 13 (2003) 41R-53R
6. Brown J.R., Fuster M.M., Whisenant T., and Esko J.D. Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys. J Biol Chem 278 (2003) 23352-23359
7. Chandrasekaran E.V., Jain R.K., and Matta K.L. Ovarian cancer alpha 1,3-L-fucosyltransferase. Differentiation of distinct catalytic species with the unique substrate, 3′-sulfo-N-acetyllactosamine in conjunction with other synthetic acceptors. J Biol Chem 267 (1992) 23806-23814
8. Chandrasekaran E.V., Xue J., Xia J., Chawda R., Piskorz C., Locke R.D., Neelamegham S., and Matta K.L. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase. Biochemistry 44 (2005) 15619-15635
9. Costa J., Grabenhorst E., Nimtz M., and Conradt H.S. Stable expression of the Golgi form and secretory variants of human fucosyltransferase III from BHK-21 cells. Purification and characterization of an engineered truncated form from the culture medium. J Biol Chem 272 (1997) 11613-11621
10. de Vries T., Srnka C.A., Palcic M.M., Swiedler S.J., van den Eijnden D.H., and Macher B.A. Acceptor specificity of different length constructs of human recombinant alpha 1,3/4-fucosyltransferases. Replacement of the stem region and the transmembrane domain of fucosyltransferase V by protein A results in an enzyme with GDP-fucose hydrolyzing activity. J Biol Chem 270 (1995) 8712-8722
11. de Vries T., Knegtel R.M., Holmes E.H., and Macher B.A. Fucosyltransferases: structure/function studies. Glycobiology 11 (2001) 119R-128R
12. Dimitroff C.J., Lechpammer M., Long-Woodward D., and Kutok J.L. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 64 (2004) 5261-5269
13. Doornik J.A.a.H.H. An omnibus test for univariate and multivariate normality. Oxford Bull Econ Stat (2008) 70
14. Escrevente C., Machado E., Brito C., Reis C.A., Stoeck A., Runz S., et al. Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines. Int J Oncol 29 (2006) 557-566
15. Gartner F., David L., Seruca R., Machado J.C., and Sobrinho-Simoes M. Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice. Virchows Arch 428 (1996) 91-98
16. Grahn A., Barkhordar G.S., and Larson G. Identification of seven new alpha2,3-sialyltransferase III, ST3Gal III, transcripts from human foetal brain. Glycoconj J 20 (2004) 493-500
17. Gretschel S., Haensch W., Schlag P.M., and Kemmner W. Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer. Oncology 65 (2003) 139-145
18. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 99 (2002) 10231-10233
19. Hanski C., Hanski M.L., Zimmer T., Ogorek D., Devine P., and Riecken E.O. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer. Cancer Res 55 (1995) 928-933
20. Harduin-Lepers A., Vallejo-Ruiz V., Krzewinski-Recchi M.A., Samyn-Petit B., Julien S., and Delannoy P. The human sialyltransferase family. Biochimie 83 (2001) 727-737
21. Harduin-Lepers A., Mollicone R., Delannoy P., and Oriol R. The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach. Glycobiology 15 (2005) 805-817
22. Higai K., Miyazaki N., Azuma Y., and Matsumoto K. Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene. FEBS Lett 580 (2006) 6069-6075
23. Higai K., Miyazaki N., Azuma Y., and Matsumoto K. Transcriptional regulation of the fucosyltransferase VI gene in hepatocellular carcinoma cells. Glycoconj J 25 (2008) 225-235
24. Holgersson J., and Lofling J. Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity. Glycobiology 16 (2006) 584-593
25. Ito H., Hiraiwa N., Sawada-Kasugai M., Akamatsu S., Tachikawa T., Kasai Y., et al. Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. Int J Cancer 71 (1997) 556-564
26. Judd L.M., Bredin K., Kalantzis A., Jenkins B.J., Ernst M., and Giraud A.S. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 131 (2006) 1073-1085
27. Kim Y.J., and Varki A. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J 14 (1997) 569-576
28. Kim Y.J., Borsig L., Varki N.M., and Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 95 (1998) 9325-9330
29. Kim Y.J., Borsig L., Han H.L., Varki N.M., and Varki A. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 155 (1999) 461-472
30. Kitagawa H., and Paulson J.C. Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase. Biochem Biophys Res Commun 194 (1993) 375-382
31. Kitagawa H., and Paulson J.C. Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. J Biol Chem 269 (1994) 1394-1401
32. Koike T., Kimura N., Miyazaki K., Yabuta T., Kumamoto K., Takenoshita S., et al. Hypoxia induces adhesion molecules on cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci USA 101 (2004) 8132-8137
33. Lanctot P.M., Gage F.H., and Varki A.P. The glycans of stem cells. Curr Opin Chem Biol 11 (2007) 373-380
34. Lofling J., and Holgersson J. Core saccharide dependence of sialyl Lewis X biosynthesis. Glycoconj J (2008)
35. Magnani J.L., Nilsson B., Brockhaus M., Zopf D., Steplewski Z., Koprowski H., et al. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem 257 (1982) 14365-14369
36. Marcos N.T., Cruz A., Silva F., Almeida R., David L., Mandel U., et al. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines. J Histochem Cytochem 51 (2003) 761-771
37. Matsushita Y., Cleary K.R., Ota D.M., Hoff S.D., and Irimura T. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases. Lab Invest 63 (1990) 780-791
38. Mollicone R., Moore S.E., Bovin N., Garcia-Rosasco M., Candelier J.J., Martinez-Duncker I., et al. Activity, splice variants, conserved peptide motifs, and phylogeny of two new alpha1,3-fucosyltransferase families (FUT10 and FUT11). J Biol Chem 284 (2009) 4723-4738
39. Nakamori S., Kameyama M., Imaoka S., Furukawa H., Ishikawa O., Sasaki Y., et al. Increased expression of sialyl Lewis x antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53 (1993) 3632-3637
40. Nakamori S., Furukawa H., Hiratsuka M., Iwanaga T., Imaoka S., Ishikawa O., et al. Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer. J Clin Oncol 15 (1997) 816-825
41. Ogawa J., Inoue H., and Koide S. Expression of alpha-1,3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer. Cancer Res 56 (1996) 325-329
42. Okajima T., Fukumoto S., Miyazaki H., Ishida H., Kiso M., Furukawa K., et al. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids. J Biol Chem 274 (1999) 11479-11486
43. Petretti T., Schulze B., Schlag P.M., and Kemmner W. Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta 1428 (1999) 209-218
44. Petretti T., Kemmner W., Schulze B., and Schlag P.M. Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 46 (2000) 359-366
45. Pykari M., Toivonen S., Natunen J., Niemela R., Salminen H., Aitio O., et al. The acceptor and site specificity of alpha 3-fucosyltransferase V. High reactivity of the proximal and low of the distal galbeta 1-4GlcNAc unit in i-type polylactosamines. J Biol Chem 275 (2000) 40057-40063
46. Radhakrishnan P., Beum P.V., Tan S., and Cheng P.W. Butyrate induces sLex synthesis by stimulation of selective glycosyltransferase genes. Biochem Biophys Res Commun 359 (2007) 457-462
47. Recchi M.A., Hebbar M., Hornez L., Harduin-Lepers A., Peyrat J.P., and Delannoy P. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res 58 (1998) 4066-4070
48. Rohfritsch P.F., Joosten J.A., Krzewinski-Recchi M.A., Harduin-Lepers A., Laporte B., Juliant S., et al. Probing the substrate specificity of four different sialyltransferases using synthetic beta-d-Galp-(1→4)-beta-d-GlcpNAc-(1→2)-alpha-d-Manp-(1→O) (CH(2))7CH3 analogues general activating effect of replacing N-acetylglucosamine by N-propionylglucosamine. Biochim Biophys Acta 1760 (2006) 685-692
49. Saito S., Yamashita S., Endoh M., Yamato T., Hoshi S., Ohyama C., et al. Clinical significance of ST3Gal IV expression in human renal cell carcinoma. Oncol Rep 9 (2002) 1251-1255
50. Sakamoto S., Watanabe T., Tokumaru T., Takagi H., Nakazato H., and Lloyd K.O. Expression of Lewisa, Lewisb, Lewisx, Lewisy, siayl-Lewisa, and sialyl-Lewisx blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res 49 (1989) 745-752
51. Sasaki K., Watanabe E., Kawashima K., Sekine S., Dohi T., Oshima M., et al. Expression cloning of a novel Gal beta (1-3/1-4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection. J Biol Chem 268 (1993) 22782-22787
52. Sasaki K., Kurata K., Funayama K., Nagata M., Watanabe E., Ohta S., Hanai N., and Nishi T. Expression cloning of a novel alpha 1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. J Biol Chem 269 (1994) 14730-14737
53. Serpa J., Mesquita P., Mendes N., Oliveira C., Almeida R., Santos-Silva F., et al. Expression of Lea in gastric cancer cell lines depends on FUT3 expression regulated by promoter methylation. Cancer Lett 242 (2006) 191-197
54. Shimodaira K., Nakayama J., Nakamura N., Hasebe O., Katsuyama T., and Fukuda M. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res 57 (1997) 5201-5206
55. Steinman R.A., Wentzel A., Lu Y., Stehle C., and Grandis J.R. Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2. Oncogene 22 (2003) 3608-3615
56. Taniguchi A., Saito K., Kubota T., and Matsumoto K. Characterization of the promoter region of the human Galbeta1,3(4)GlcNAc alpha2,3-sialyltransferase III (hST3Gal III) gene. Biochim Biophys Acta 1626 (2003) 92-96
57. Taniguchi A. Promoter structure and transcriptional regulation of human beta-galactoside alpha2,3-sialyltransferase genes. Curr Drug Targets 9 (2008) 310-316
58. Tsuji S. Molecular cloning and functional analysis of sialyltransferases. J Biochem 120 (1996) 1-13
59. Weston B.W., Smith P.L., Kelly R.J., and Lowe J.B. Molecular cloning of a fourth member of a human alpha (1,3)fucosyltransferase gene family. Multiple homologous sequences that determine expression of the Lewis x, sialyl Lewis x, and difucosyl sialyl Lewis x epitopes. J Biol Chem 267 (1992) 24575-24584
60. Yakata Y., Nakayama T., Yoshizaki A., Kusaba T., Inoue K., and Sekine I. Expression of p-STAT3 in human gastric carcinoma: significant correlation in tumour invasion and prognosis. Int J Oncol 30 (2007) 437-442
61. Yu L.F., Zhu Y.B., Qiao M.M., Zhong J., Tu S.P., and Wu Y.L. Constitutive activation and clinical significance of Stat3 in human gastric cancer tissues and cell lines. Zhonghua Yi Xue Za Zhi 84 (2004) 2064-2069